These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 11758521)

  • 1. Cannabinoids in pain management. Few well controlled trials of cannabis exist for systemic review.
    Iversen L
    BMJ; 2001 Nov; 323(7323):1250; author reply 1250-1. PubMed ID: 11758521
    [No Abstract]   [Full Text] [Related]  

  • 2. Cannabinoids in pain management. Study was bound to conclude that cannabinoids had limited efficacy.
    Russo E
    BMJ; 2001 Nov; 323(7323):1249-50; author reply 1250-1. PubMed ID: 11719420
    [No Abstract]   [Full Text] [Related]  

  • 3. Cannabis-based medicinal products in arthritis, a painful conundrum.
    Berg MVD; John M; Black M; Semprini A; Oldfield K; Glass M; Braithwaite I
    N Z Med J; 2020 May; 133(1515):35-45. PubMed ID: 32438375
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacological actions and therapeutic uses of cannabis and cannabinoids.
    Kumar RN; Chambers WA; Pertwee RG
    Anaesthesia; 2001 Nov; 56(11):1059-68. PubMed ID: 11703238
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [News about therapeutic use of Cannabis and endocannabinoid system].
    Duran M; Laporte JR; Capellà D
    Med Clin (Barc); 2004 Mar; 122(10):390-8. PubMed ID: 15033046
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Use of Cannabis and Cannabinoids in Treating Symptoms of Multiple Sclerosis: a Systematic Review of Reviews.
    Nielsen S; Germanos R; Weier M; Pollard J; Degenhardt L; Hall W; Buckley N; Farrell M
    Curr Neurol Neurosci Rep; 2018 Feb; 18(2):8. PubMed ID: 29442178
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Systematic review of safeness and therapeutic efficacy of cannabis in patients with multiple sclerosis, neuropathic pain, and in oncological patients treated with chemotherapy].
    Amato L; Minozzi S; Mitrova Z; Parmelli E; Saulle R; Cruciani F; Vecchi S; Davoli M
    Epidemiol Prev; 2017; 41(5-6):279-293. PubMed ID: 29119763
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Therapeutic potential of cannabis in pain medicine.
    Hosking RD; Zajicek JP
    Br J Anaesth; 2008 Jul; 101(1):59-68. PubMed ID: 18515270
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cannabinoids, cannabis, and cannabis-based medicines for pain management: an overview of systematic reviews.
    Moore RA; Fisher E; Finn DP; Finnerup NB; Gilron I; Haroutounian S; Krane E; Rice ASC; Rowbotham M; Wallace M; Eccleston C
    Pain; 2021 Jul; 162(Suppl 1):S67-S79. PubMed ID: 32804833
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Medicinal cannabis extracts for the treatment of multiple sclerosis.
    Smith PF
    Curr Opin Investig Drugs; 2004 Jul; 5(7):727-30. PubMed ID: 15298068
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plant, synthetic, and endogenous cannabinoids in medicine.
    Di Marzo V; Petrocellis LD
    Annu Rev Med; 2006; 57():553-74. PubMed ID: 16409166
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cannabis, pain, and sleep: lessons from therapeutic clinical trials of Sativex, a cannabis-based medicine.
    Russo EB; Guy GW; Robson PJ
    Chem Biodivers; 2007 Aug; 4(8):1729-43. PubMed ID: 17712817
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Cannabis medicinal drugs. "Psychedelics" by prescription?].
    Gross H
    MMW Fortschr Med; 2010 Nov; 152(45):14-6. PubMed ID: 21319400
    [No Abstract]   [Full Text] [Related]  

  • 14. Cannabis, Cannabinoids, and the Endocannabinoid System-Is there Therapeutic Potential for Inflammatory Bowel Disease?
    Ambrose T; Simmons A
    J Crohns Colitis; 2019 Mar; 13(4):525-535. PubMed ID: 30418525
    [TBL] [Abstract][Full Text] [Related]  

  • 15. International Association for the Study of Pain Presidential Task Force on Cannabis and Cannabinoid Analgesia: research agenda on the use of cannabinoids, cannabis, and cannabis-based medicines for pain management.
    Haroutounian S; Arendt-Nielsen L; Belton J; Blyth FM; Degenhardt L; Di Forti M; Eccleston C; Finn DP; Finnerup NB; Fisher E; Fogarty AE; Gilron I; Hohmann AG; Kalso E; Krane E; Mohiuddin M; Moore RA; Rowbotham M; Soliman N; Wallace M; Zinboonyahgoon N; Rice ASC
    Pain; 2021 Jul; 162(Suppl 1):S117-S124. PubMed ID: 34138827
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The legalization of Cannabis for medical use.
    Moffat AC
    Sci Justice; 2002; 42(1):55-7. PubMed ID: 12012651
    [No Abstract]   [Full Text] [Related]  

  • 17. Cannabis and cannabinoids for symptomatic treatment for people with multiple sclerosis.
    Filippini G; Minozzi S; Borrelli F; Cinquini M; Dwan K
    Cochrane Database Syst Rev; 2022 May; 5(5):CD013444. PubMed ID: 35510826
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evidence for using cannabis and cannabinoids to manage pain.
    Wood S
    Nurs Times; 2004 Dec 7-13; 100(49):38-40. PubMed ID: 15630971
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Canadian clinical practice guidelines for the use of plant-based cannabis and cannabinoid-based products in the management of chronic non-cancer pain and co-occurring conditions: protocol for a systematic literature review.
    Wright P; Walsh Z; Margolese S; Sanchez T; Arlt S; Belle-Isle L; St Pierre M; Bell A; Daeninck P; Gagnon M; Lacasse G; MacCallum C; Mandarino E; Yale J; O'Hara J; Costiniuk C
    BMJ Open; 2020 May; 10(5):e036114. PubMed ID: 32448797
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Medicinal cannabis for diseases of the nervous system: no convincing evidence of effectiveness].
    Killestein J; Bet PM; van Loenen AC; Polman CH
    Ned Tijdschr Geneeskd; 2004 Nov; 148(48):2374-8. PubMed ID: 15615271
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.